Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1996 Aug 15;24(16):3216–3221. doi: 10.1093/nar/24.16.3216

Multiple phenotypes associated with Myc-induced transformation of chick embryo fibroblasts can be dissociated by a basic region mutation.

D H Crouch 1, R Gallagher 1, C R Goding 1, J C Neil 1, R Fulton 1
PMCID: PMC146082  PMID: 8774903

Abstract

Chimaeric alleles were constructed to assay the biological functions of an N-terminal deletion and C-terminal mutations which were found in a naturally occurring mutant of feline vMyc, T17. The mutant alleles were assayed for their ability to transform chick embryo fibroblasts in vitro by a number of criteria, namely the ability to induce morphological transformation, an accelerated growth rate and growth in soft agar. Feline cMyc could transform the avian cells, whilst T17 vMyc could not, and the N-terminal deletion was responsible for conferring the primary transformation defect on the mutant protein. The C-terminal mutations which consist of a point mutation adjacent to the nuclear localisation signal and a point mutation/amino acid insertion within the basic region (BR) could, however, dissociate the Myc-induced parameters of transformation. This effect was a specific function of the BR mutation alone, and the mutation could be transferred into avian cMyc with comparable biological consequences. The BR mutation did not disrupt the sequence specific DNA binding activity of the protein in vivo, despite exerting a biological effect. These data suggest a novel phenotype where the mutation may affect a subset of Myc-regulated genes through altered DNA binding specificity or protein-protein interactions.

Full Text

The Full Text of this article is available as a PDF (119.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert T., Urlbauer B., Kohlhuber F., Hammersen B., Eick D. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. Oncogene. 1994 Mar;9(3):759–763. [PubMed] [Google Scholar]
  2. Amati B., Brooks M. W., Levy N., Littlewood T. D., Evan G. I., Land H. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell. 1993 Jan 29;72(2):233–245. doi: 10.1016/0092-8674(93)90663-b. [DOI] [PubMed] [Google Scholar]
  3. Amati B., Land H. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev. 1994 Feb;4(1):102–108. doi: 10.1016/0959-437x(94)90098-1. [DOI] [PubMed] [Google Scholar]
  4. Amati B., Littlewood T. D., Evan G. I., Land H. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J. 1993 Dec 15;12(13):5083–5087. doi: 10.1002/j.1460-2075.1993.tb06202.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Baxevanis A. D., Vinson C. R. Interactions of coiled coils in transcription factors: where is the specificity? Curr Opin Genet Dev. 1993 Apr;3(2):278–285. doi: 10.1016/0959-437x(93)90035-n. [DOI] [PubMed] [Google Scholar]
  6. Bengal E., Flores O., Rangarajan P. N., Chen A., Weintraub H., Verma I. M. Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6221–6225. doi: 10.1073/pnas.91.13.6221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bhatia K., Huppi K., Spangler G., Siwarski D., Iyer R., Magrath I. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat Genet. 1993 Sep;5(1):56–61. doi: 10.1038/ng0993-56. [DOI] [PubMed] [Google Scholar]
  8. Blackwell T. K., Kretzner L., Blackwood E. M., Eisenman R. N., Weintraub H. Sequence-specific DNA binding by the c-Myc protein. Science. 1990 Nov 23;250(4984):1149–1151. doi: 10.1126/science.2251503. [DOI] [PubMed] [Google Scholar]
  9. Blackwell T. K., Weintraub H. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science. 1990 Nov 23;250(4984):1104–1110. doi: 10.1126/science.2174572. [DOI] [PubMed] [Google Scholar]
  10. Blackwood E. M., Eisenman R. N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science. 1991 Mar 8;251(4998):1211–1217. doi: 10.1126/science.2006410. [DOI] [PubMed] [Google Scholar]
  11. Brough D. E., Hofmann T. J., Ellwood K. B., Townley R. A., Cole M. D. An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation. Mol Cell Biol. 1995 Mar;15(3):1536–1544. doi: 10.1128/mcb.15.3.1536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cole M. D. The myc oncogene: its role in transformation and differentiation. Annu Rev Genet. 1986;20:361–384. doi: 10.1146/annurev.ge.20.120186.002045. [DOI] [PubMed] [Google Scholar]
  13. Crouch D. H., Fisher F., Clark W., Jayaraman P. S., Goding C. R., Gillespie D. A. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity. Oncogene. 1993 Jul;8(7):1849–1855. [PubMed] [Google Scholar]
  14. Crouch D. H., Lang C., Gillespie D. A. The leucine zipper domain of avian cMyc is required for transformation and autoregulation. Oncogene. 1990 May;5(5):683–689. [PubMed] [Google Scholar]
  15. Dang C. V., Lee W. M. Identification of the human c-myc protein nuclear translocation signal. Mol Cell Biol. 1988 Oct;8(10):4048–4054. doi: 10.1128/mcb.8.10.4048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Desbarats L., Gaubatz S., Eilers M. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes Dev. 1996 Feb 15;10(4):447–460. doi: 10.1101/gad.10.4.447. [DOI] [PubMed] [Google Scholar]
  17. Dong Q., Blatter E. E., Ebright Y. W., Bister K., Ebright R. H. Identification of amino acid-base contacts in the Myc-DNA complex by site-specific bromouracil mediated photocrosslinking. EMBO J. 1994 Jan 1;13(1):200–204. doi: 10.1002/j.1460-2075.1994.tb06249.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Evan G. I., Littlewood T. D. The role of c-myc in cell growth. Curr Opin Genet Dev. 1993 Feb;3(1):44–49. doi: 10.1016/s0959-437x(05)80339-9. [DOI] [PubMed] [Google Scholar]
  19. Evan G. I., Wyllie A. H., Gilbert C. S., Littlewood T. D., Land H., Brooks M., Waters C. M., Penn L. Z., Hancock D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992 Apr 3;69(1):119–128. doi: 10.1016/0092-8674(92)90123-t. [DOI] [PubMed] [Google Scholar]
  20. Farina S. F., Huff J. L., Parsons J. T. Mutations within the 5' half of the avian retrovirus MC29 v-myc gene alter or abolish transformation of chicken embryo fibroblasts and macrophages. J Virol. 1992 May;66(5):2698–2708. doi: 10.1128/jvi.66.5.2698-2708.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Feldmann T., Alex R., Suckow J., Dildrop R., Kisters-Woike B., Müller-Hill B. Single exchanges of amino acids in the basic region change the specificity of N-Myc. Nucleic Acids Res. 1993 Nov 11;21(22):5050–5058. doi: 10.1093/nar/21.22.5050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ferré-D'Amaré A. R., Prendergast G. C., Ziff E. B., Burley S. K. Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature. 1993 May 6;363(6424):38–45. doi: 10.1038/363038a0. [DOI] [PubMed] [Google Scholar]
  23. Fisher F., Crouch D. H., Jayaraman P. S., Clark W., Gillespie D. A., Goding C. R. Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo. EMBO J. 1993 Dec 15;12(13):5075–5082. doi: 10.1002/j.1460-2075.1993.tb06201.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Fisher F., Goding C. R. Single amino acid substitutions alter helix-loop-helix protein specificity for bases flanking the core CANNTG motif. EMBO J. 1992 Nov;11(11):4103–4109. doi: 10.1002/j.1460-2075.1992.tb05503.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fisher F., Jayaraman P. S., Goding C. R. C-myc and the yeast transcription factor PHO4 share a common CACGTG-binding motif. Oncogene. 1991 Jul;6(7):1099–1104. [PubMed] [Google Scholar]
  26. Frykberg L., Graf T., Vennström B. The transforming activity of the chicken c-myc gene can be potentiated by mutations. Oncogene. 1987;1(4):415–422. [PubMed] [Google Scholar]
  27. Fuerstenberg S., Beug H., Introna M., Khazaie K., Muñoz A., Ness S., Nordström K., Sap J., Stanley I., Zenke M. Ectopic expression of the erythrocyte band 3 anion exchange protein, using a new avian retrovirus vector. J Virol. 1990 Dec;64(12):5891–5902. doi: 10.1128/jvi.64.12.5891-5902.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Fulton R., Forrest D., McFarlane R., Onions D., Neil J. C. Retroviral transduction of T-cell antigen receptor beta-chain and myc genes. Nature. 1987 Mar 12;326(6109):190–194. doi: 10.1038/326190a0. [DOI] [PubMed] [Google Scholar]
  29. Fulton R., Gallagher R., Crouch D., Neil J. C. Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced by feline leukemia virus. J Virol. 1996 Feb;70(2):1154–1162. doi: 10.1128/jvi.70.2.1154-1162.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Gupta S., Seth A., Davis R. J. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3216–3220. doi: 10.1073/pnas.90.8.3216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Heaney M. L., Pierce J., Parsons J. T. Site-directed mutagenesis of the gag-myc gene of avian myelocytomatosis virus 29: biological activity and intracellular localization of structurally altered proteins. J Virol. 1986 Oct;60(1):167–176. doi: 10.1128/jvi.60.1.167-176.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hoang A. T., Lutterbach B., Lewis B. C., Yano T., Chou T. Y., Barrett J. F., Raffeld M., Hann S. R., Dang C. V. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol Cell Biol. 1995 Aug;15(8):4031–4042. doi: 10.1128/mcb.15.8.4031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Hughes S. H., Greenhouse J. J., Petropoulos C. J., Sutrave P. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J Virol. 1987 Oct;61(10):3004–3012. doi: 10.1128/jvi.61.10.3004-3012.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Kato G. J., Barrett J., Villa-Garcia M., Dang C. V. An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol. 1990 Nov;10(11):5914–5920. doi: 10.1128/mcb.10.11.5914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. La Rocca S. A., Crouch D. H., Gillespie D. A. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation. Oncogene. 1994 Dec;9(12):3499–3508. [PubMed] [Google Scholar]
  36. Li L. H., Nerlov C., Prendergast G., MacGregor D., Ziff E. B. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 1994 Sep 1;13(17):4070–4079. doi: 10.1002/j.1460-2075.1994.tb06724.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Murre C., McCaw P. S., Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell. 1989 Mar 10;56(5):777–783. doi: 10.1016/0092-8674(89)90682-x. [DOI] [PubMed] [Google Scholar]
  38. Penn L. J., Laufer E. M., Land H. C-MYC: evidence for multiple regulatory functions. Semin Cancer Biol. 1990 Feb;1(1):69–80. [PubMed] [Google Scholar]
  39. Prendergast G. C., Ziff E. B. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science. 1991 Jan 11;251(4990):186–189. doi: 10.1126/science.1987636. [DOI] [PubMed] [Google Scholar]
  40. Solomon D. L., Amati B., Land H. Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers. Nucleic Acids Res. 1993 Nov 25;21(23):5372–5376. doi: 10.1093/nar/21.23.5372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Stone J., de Lange T., Ramsay G., Jakobovits E., Bishop J. M., Varmus H., Lee W. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol. 1987 May;7(5):1697–1709. doi: 10.1128/mcb.7.5.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Symonds G., Hartshorn A., Kennewell A., O'Mara M. A., Bruskin A., Bishop J. M. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential. Oncogene. 1989 Mar;4(3):285–294. [PubMed] [Google Scholar]
  43. Terry A., Fulton R., Stewart M., Onions D. E., Neil J. C. Pathogenesis of feline leukemia virus T17: contrasting fates of helper, v-myc, and v-tcr proviruses in secondary tumors. J Virol. 1992 Jun;66(6):3538–3549. doi: 10.1128/jvi.66.6.3538-3549.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES